Open Access Rheumatology-Research and Reviews

Scope & Guideline

Connecting Minds, Sharing Discoveries in Rheumatology.

Introduction

Explore the comprehensive scope of Open Access Rheumatology-Research and Reviews through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Open Access Rheumatology-Research and Reviews in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1179-156x
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationOPEN ACCESS RHEUMATO / Open Access Rehumatol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Open Access Rheumatology - Research and Reviews' focuses on advancing the understanding and treatment of rheumatic diseases through comprehensive research articles, reviews, and clinical studies. Its aims and scopes reflect a commitment to exploring a wide range of topics relevant to both clinical practice and basic research in rheumatology.
  1. Rheumatoid Arthritis Research:
    A core focus of the journal is on rheumatoid arthritis, encompassing studies on its pathophysiology, treatment efficacy, and patient outcomes. This includes research on both traditional and biologic therapies, as well as the impacts of comorbidities.
  2. Innovative Therapeutics and Treatment Paradigms:
    The journal publishes articles on new therapeutic agents, including JAK inhibitors and biosimilars, emphasizing clinical trial results, real-world data, and treatment strategies.
  3. Patient-Centered Research:
    There is a consistent emphasis on patient-reported outcomes, quality of life, and psychosocial aspects of rheumatic diseases, highlighting the importance of patient perspectives in managing these conditions.
  4. Comorbidities and Systemic Impacts:
    Research on the interplay between rheumatic diseases and other health conditions, such as cardiovascular disease, metabolic syndrome, and pregnancy outcomes, is a significant area of focus.
  5. Diagnostic Innovations:
    The journal addresses advancements in diagnostic techniques and biomarkers, aiming to improve early detection and management of rheumatic diseases.
  6. Global Health Perspectives:
    The journal includes studies that explore the prevalence, treatment patterns, and healthcare resource utilization in different geographic regions, contributing to a global understanding of rheumatology.
Recent publications in 'Open Access Rheumatology - Research and Reviews' indicate several emerging themes that are gaining traction within the field of rheumatology. The following points summarize these trending areas of interest.
  1. Personalized Medicine:
    A notable increase in research focusing on personalized treatment approaches for rheumatic diseases, including the use of biomarkers to tailor therapies to individual patient profiles.
  2. Impact of Comorbidities:
    Emerging studies are increasingly examining how comorbid conditions affect the management and outcomes of rheumatic diseases, highlighting the need for comprehensive care strategies.
  3. Longitudinal and Real-World Data Studies:
    There is a growing trend towards utilizing real-world data and longitudinal studies to assess treatment effectiveness and safety in diverse patient populations, providing valuable insights into everyday clinical practice.
  4. Mental Health and Psychosocial Factors:
    Research exploring the psychological aspects of rheumatic diseases, including depression and anxiety in patients, is becoming more prominent, recognizing the holistic nature of patient care.
  5. Innovative Diagnostic Tools:
    The development and validation of new diagnostic techniques, including imaging and biomarker studies, are increasingly featured, reflecting advancements in the early detection and management of rheumatic conditions.

Declining or Waning

While 'Open Access Rheumatology - Research and Reviews' continues to thrive in numerous areas, certain themes appear to be diminishing in prominence based on recent publications. The following points highlight these waning scopes.
  1. Traditional Disease Modifying Antirheumatic Drugs (DMARDs):
    Research on conventional DMARDs, such as methotrexate, has seen a decline as the focus shifts toward biologic therapies and newer agents, suggesting a transition in treatment paradigms.
  2. Basic Science without Clinical Relevance:
    There seems to be a reduced emphasis on purely basic science studies that do not translate into clinical applications or patient outcomes, reflecting a growing preference for research with direct clinical implications.
  3. Gout Research:
    Although still relevant, studies specifically focused on gout management and its complications appear to be less frequent, potentially overshadowed by the more complex and prevalent issues in rheumatoid arthritis and other autoimmune diseases.

Similar Journals

SEMINARS IN ARTHRITIS AND RHEUMATISM

Elevating research standards in arthritis and rheumatism.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Arthritis & Rheumatology

Advancing Knowledge in Rheumatology and Immunology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Archives of Rheumatology

Connecting global minds to transform rheumatologic care.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Reumatologia Clinica

Elevating the standard of care in rheumatology.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.

Reumatismo

Empowering healthcare through innovative rheumatology insights.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Fostering collaboration through rigorous research and case studies.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

International Journal of Rheumatology

Fostering excellence in rheumatology through open access.
Publisher: HINDAWI LTDISSN: 1687-9260Frequency: 1 issue/year

The International Journal of Rheumatology, published by HINDAWI LTD, serves as a vital resource for researchers and practitioners in the fields of rheumatology and immunology. Since its inception in 2009 as an Open Access journal, it has aimed to disseminate high-quality, peer-reviewed research to foster advancements in the understanding and treatment of rheumatic diseases. With an ISSN of 1687-9260 and E-ISSN of 1687-9279, the journal has become increasingly relevant, achieving a respectable Q3 ranking in both the Immunology and Rheumatology categories in 2023, and earning a Scopus rank of #27 out of 73 in Medicine Rheumatology. The journal's commitment to excellence is reflected in its wide-ranging scope, addressing current trends and innovations through empirical studies, reviews, and clinical insights. Its global readership, based in the United States and beyond, highlights the journal's importance in shaping the discourse within rheumatological research. As it converges through the years from 2010 to 2024, the International Journal of Rheumatology continues to be a cornerstone for sharing groundbreaking findings and fostering collaboration in the rheumatic disease community.

Revista Cubana de Reumatologia

Fostering innovation in the management of rheumatic conditions.
Publisher: SOC CUBANA REUMATOLOGIAISSN: 1606-5581Frequency: 2 issues/year

Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.

ACR Open Rheumatology

Connecting the global rheumatology community through unrestricted access.
Publisher: WILEYISSN: Frequency: 12 issues/year

ACR Open Rheumatology, published by WILEY, is a premier open-access journal dedicated to advancing the field of rheumatology. Since its inception in 2019, this journal has rapidly gained recognition, achieving a Q1 category ranking in the 2023 Scopus Quartiles, positioning it among the top 30% within its discipline. With a current Scopus rank of 22 out of 73 in Medicine - Rheumatology and an impressive 70th percentile, ACR Open Rheumatology serves as a vital platform for researchers and clinicians to disseminate knowledge on the latest developments in rheumatic diseases and treatments. The journal promotes unrestricted access to cutting-edge research, thus fostering collaboration and innovation in the rheumatological community. Situated in the United States, it caters to a global audience, encouraging submissions from researchers worldwide and addressing critical health issues that affect millions. We invite professionals, students, and researchers alike to engage with the transformative findings published in our journal.

Lancet Rheumatology

Unveiling the latest breakthroughs in rheumatological research.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.